Development and therapeutic potential of calpain inhibitors.
Wang
K K
KK
Department of Neuroscience Therapeutics Parke-Davis Pharmaceutical Research Warner-Lambert Company, Ann Arbor, Michigan 48105, USA.
Yuen
P W
PW
D000818:Animals; D002118:Calcium / Q000378:metabolism; D002154:Calpain / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000494:pharmacology; D002386:Cataract / Q000209:etiology; D002493:Central Nervous System Diseases / Q000517:prevention & control*; D006801:Humans; D009136:Muscular Dystrophies / Q000235:genetics / Q000517:prevention & control; D017202:Myocardial Ischemia / Q000517:prevention & control; D011506:Proteins / Q000378:metabolism
D011506:Proteins; D002154:Calpain; D002118:Calcium